Table 1.
(Taken from “management of autoimmune retinopathies with Immunosuppression.Arch Ophthalmol.2009; 127 (4):390–397.Henry.A.Ferreyra, Thiran Jayasundera, Naheed W.Khan, Shirley He,Ying,Lu, John R. Heckenlively”.5
| DIAGNOSTIC CRITERIA FOR AUTOIMMUNE RETINOPATHY5 | ||
|---|---|---|
| Strong Evidence | Supportive Evidence | Helpful Evidence |
| Diffuse retinal atrophy | Abnormal ERG, typical symptoms, no pigment deposits | Anti-arrestin antibody |
| Severely diminished/extinguished a and b waves, negative waves in ERG | Sudden onset of photopsias; prev normal VA | Anti -enolase antibody |
| Antirecoverin antibody | Rapid progression by history or visual fields | No family h/o of RP |
| Response to trial of Methylprednisolone | Multiple antiretinal anibody bands on Western blot testing | |
| CME in panretinal degeneration | Family h/o of autoimmune disease | |
| Family h/o of autoimmune disease | ||
| H/o autoimmune disease in 50% of immediate family | ||